Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with β-thalassaemia major: application of SQUID biomagnetic liver susceptometry-Reference-Cited by-同舟云学术

Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with β-thalassaemia major: application of SQUID biomagnetic liver susceptometry

Published:2003-06 Issue:6 Volume:121 Page:938-948
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Fischer Roland,Longo Filomena,Nielsen Peter,Engelhardt Rainer,Hider Robert C.,Piga Antonio

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04297.x/fullpdf

Reference50 articles.

1. Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial;Agarwal;British Journal of Haematology,1992

2. Efficacy and possible adverse effects of the oral iron chelator 1,2- dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major;Al-Refaie;Blood,1992

3. Changes in transferrin saturation after treatment with the oral iron chelator deferiprone in patients with iron overload;Al-Refaie;Journal of Clinical Pathology,1995a

4. Results of long-term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators;Al-Refaie;British Journal of Haematology,1995b

5. Pharmacokinetics of the oral iron chelator deferiprone (L1) in patients with iron overload;Al-Refaie;British Journal of Haematology,1995c

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active transport nanochelators for the reduction of liver iron burden in iron overload;Journal of Controlled Release;2022-10

2. Thalassaemia;The Lancet;2022-06

3. Iron Chelators in Treatment of Iron Overload;Journal of Toxicology;2022-05-05

4. Cardiac Magnetic Resonance at 3.0 T in Patients With C282Y Homozygous Hereditary Hemochromatosis;Journal of Thoracic Imaging;2022-04-18

5. Characterisation of individual ferritin response in patients receiving chelation therapy;British Journal of Clinical Pharmacology;2022-03-26